UK Laboratory Dispatch:
UK Legal Matrix
PeptidesUK.org
British Clinical Chemical Registry
Analytical Chromatography & Mass Spectrometry

Analytical Quality Standards & Verification Protocol

Every synthetic peptide monograph cataloged by Peptides-UK mandates rigorous orthogonal analytical confirmation before being indexed. We establish a non-negotiable benchmark across chromatographic purity, molecular mass validation, residual solvent content, and third-party laboratory verification.

Analytical Modalities

The 5-Pillar Laboratory Verification Architecture

Single-modality testing is chemically insufficient to certify research peptides. Our framework requires orthogonal multi-spectral verification to eliminate synthetic impurities and sequence truncation errors.

MODALITY 01≥98.0% Baseline

Reverse-Phase HPLC (RP-HPLC)

Utilizes a C18 stationary phase column and an acetonitrile/water gradient with 0.1% trifluoroacetic acid (TFA). Integrates peak absorbance at 214 nm (peptide bond backbone) and 254 nm (aromatic side chains) to detect early-eluting truncated sequences and late-eluting hydrophobic impurities.

Column: C18 Silica 4.6 × 250 mm, 5 µm
Flow Rate: 1.0 mL/min isocratic/gradient
MODALITY 02±0.5 Da Variance

Electrospray Ionization MS (ESI-MS)

Provides soft ionization without thermal decomposition, measuring mass-to-charge (m/z) ratios. Confirms that the molecular weight corresponds precisely to the theoretical monoisotopic mass, verifying that no amino acid residue deletions, additions, or oxidation events occurred during solid-phase synthesis.

Mass Range: 200 – 10,000 m/z
Deconvolution: Multi-charge state resolution
MODALITY 03<10 EU/mg

Endotoxin Chromogenic LAL Assay

Quantifies bacterial lipopolysaccharide (LPS) pyrogen levels using the Limulus Amebocyte Lysate (LAL) colorimetric substrate reaction. Critical for in vitro cell culture assays to ensure that cellular activation or cytokine responses are not artifactual reactions to bacterial contamination.

Sensitivity: 0.005 EU/mL lower detection limit
Standard: European Pharmacopoeia (Ph. Eur. 2.6.14)
MODALITY 04<5.0% Karl Fischer

Moisture Content & Net Peptide Content

Lyophilized peptide vials contain counter-ions (acetate or trifluoroacetate salts) and residual hydration water. Coulometric Karl Fischer titration determines true moisture percentage, enabling investigators to accurately calculate net active peptide mass versus gross vial powder weight.

Titration: Coulometric Karl Fischer oven method
Net Peptide Factor: Typically 75% – 85% of gross cake
MODALITY 05ICP-MS Profiling

Residual Catalyst & Heavy Metal Trace

Inductively Coupled Plasma Mass Spectrometry (ICP-MS) screens for trace synthesis coupling reagents and toxic heavy metals (lead, arsenic, cadmium, mercury, palladium). Confirms compliance with ICH Q3D elemental impurity thresholds for ultra-pure research standards.

Limit of Quantitation: <0.1 ppm
ICH Q3D Guideline Class 1 & 2A metals screen
AUDIT CRITERIAISO 17025 Required

Third-Party Independent Laboratory Testing

Manufacturer in-house testing carries inherent commercial conflict of interest. We require all verified UK vendors to submit random production batches to accredited independent European contract research organizations (CROs) maintaining ISO/IEC 17025 certification.

Accreditation: ISO/IEC 17025:2017
Audit Cycle: Batch-specific COA verification
Laboratory Due Diligence

The 7-Point Certificate of Analysis (COA) Audit Protocol

When reviewing supplier documentation, British research institutions must scrutinize every Certificate of Analysis against these seven essential authenticity criteria:

1
Unique Traceable Lot / Batch Number

The lot number printed on the COA must match the physical label on the lyophilized glass vial exactly, allowing retrospective traceability to the specific solid-phase synthesis run.

2
Full High-Resolution HPLC Chromatogram

Legitimate COAs display the raw chromatographic trace with explicit X-axis (retention time in minutes) and Y-axis (mAU absorbance units), including the integrated peak report table showing peak area percentages.

3
Explicit HPLC Analytical Parameters

The COA must state the column type (e.g., Inertsil ODS-3, 4.6×250mm), detection wavelength (214 nm), mobile phase gradient composition, flow rate, and column oven temperature.

4
ESI Mass Spectrum with Resolved Ion Peaks

The mass spectrum must present clear parent ion ([M+H]+) and multi-charged species ([M+2H]2+, [M+3H]3+) confirming the compound identity against calculated theoretical mass within ±0.5 Da.

5
Third-Party Analytical Laboratory Identification

The report must identify the independent contract analytical facility, laboratory accreditation number, and physical testing address, rather than an anonymous generic template.

6
Testing Date & Retest Shelf-Life Window

The COA must date the analysis within an acceptable testing timeframe and declare the validated stability window under recommended storage conditions (-20°C desiccated).

7
Principal Chemist Signature & Quality Release

Formal sign-off by a designated analytical chemist and quality assurance manager certifying that the batch meets all defined acceptance criteria.

Compare Verified UK Laboratory Suppliers

Inspect our independent audit of Britain's 5 verified suppliers, cross-referencing HPLC purity baselines, borosilicate packaging protocols, and tracked cold-chain dispatch.

View 5 Audited UK Suppliers